[1] Katta N, Loethen T, Lavie CJ, Alpert MA.Obesity and Coronary Heart Disease: Epidemiology, Pathology, and Coronary Artery Imaging[J]. Curr Probl Cardiol. 2021;46(3):100655.
[2] Tao S, Tang X, Yu L, et al. Prognosis of coronary heart disease after percutaneous coronary intervention: a bibliometric analysis over the period2004-2022[J]. Eur J Med Res. 2023;28(1):311. Published 2023 Sep 1.
[3] Shen L, Yang T, Xia K, et al. P-selectin (CD62P) andsoluble TREM-like transcript-1 (sTLT-1) are associated with coronary artery disease: a case control study. BMC Cardiovasc Disord.2020;20(1):387. Published 2020 Aug 24.
[4] 金子安,李杰,陈阳. 夏橘化瘀胶囊对冠心病患者经皮冠状动脉介入治疗后支架内再狭窄及血清炎性因子水平的影响研究[J]. 实用心脑肺血管病杂志,2018,26(7):82-85.
[5] 中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会. 中国经皮冠状动脉介入治疗指南(2016)[J]. 中华心血管病杂志,2016,44(5):382-400.
[6] Gallone G, Bellettini M, Gatti M, et al.Coronary Plaque Characteristics Associated With Major Adverse Cardiovascular Events in Atherosclerotic Patients and Lesions: A Systematic Review and Meta-Analysis [published correction appears in JACC Cardiovasc Imaging[J]. JACC Cardiovasc Imaging. 2023;16(12):1584-1604.
[7] 占文明,闫旭. NT-proBNP、GDF-15水平变化与老年冠心病患者PCI术后发生心力衰竭的关系[J]. 检验医学与临床,2021,18(23):3439-3442.
[8] 张翥,范修才,陶亮亮,等. 血小板相关实验室指标预测老年经皮冠状动脉介入术后患者主要心血管不良事件的价值[J]. 实用临床医药杂志,2022,26(24):86-89,106.
[9] 蔡宇豪,王崇丽,江丽丽. 外周血GDF-15和β2-MG表达水平与冠心病介入治疗患者术后支架内再狭窄的关系[J]. 临床和实验医学杂志,2020,19(21):2278-2281.
[10] 印章,付永波,朱冬梅,等. 血清CD62P、sTREM-1水平预测老年冠心病患者PCI术后主要心血管不良事件发生的价值[J]. 标记免疫分析与临床,2024,31(3):491-495,568.
[11] 闫丙军,杨利梅,刘凯. 血清NT-proBNP、sd-LDL、GDF-15、hs-CRP/PA水平变化与老年冠心病患者PCI术后发生MACE的关系[J]. 分子诊断与治疗杂志,2023,15(8):1305-1309. |
